SPECIALE, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 1.150
Totale 1.150
Nazione #
IT - Italia 1.150
Totale 1.150
Città #
Genova 684
Rapallo 253
Genoa 208
Bordighera 5
Totale 1.150
Nome #
Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma 183
Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation 112
Modulazione di CD44/xCT come possibile strategia per contrastare la resistenza all'Etoposide di cellule staminali del cancro 99
MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance 92
Glutathione and the switch of aerobic metabolism collaborate for multi-drug resistance of neuroblastoma 91
Targeting CD44/xCT is a potential strategy to sensitize human neuroblastoma stem cells to etoposide 84
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809 83
Pkcα inhibition as a strategy to sensitize neuroblastoma stem cells to etoposide by stimulating ferroptosis 61
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma 58
CD44/xCT inhibition is a potential strategy to sensitize cancer stem cells to etoposide pro-oxidant effects 57
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 47
xCT/CD44 modulation induces the sensitization of neuroblastoma-stem cells to etoposide. 45
“The Blinded Guardian”: clinical relevance of p53-null phenotype in high-grade serous ovarian cancers 38
Evaluating the influence of a g-quadruplex prone sequence on the transactivation potential by wild-type and/or mutant p53 family proteins through a yeast-based functional assay 35
Antitumor effects of PRIMA-1 and PRIMA-1met (APR246) in hematological malignancies: Still a mutant p53-dependent affair? 33
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? 33
Mutant p53K120R expression enables a partial capacity to modulate metabolism 24
MicroRNA-Mutant P53 Crosstalk in Chemoresistance: A Hint to Monitor Therapy Outcome 15
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget) 14
Totale 1.204
Categoria #
all - tutte 4.580
article - articoli 4.340
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 19 12
2019/2020266 14 6 6 13 25 28 44 27 25 46 26 6
2020/2021141 3 9 17 8 9 11 9 19 11 13 23 9
2021/2022221 9 8 17 50 9 13 8 42 12 17 7 29
2022/2023317 20 40 2 47 29 47 0 22 44 2 55 9
2023/2024161 5 18 4 27 24 28 17 15 4 19 0 0
Totale 1.204